UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2021~~ 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

SCVX Corp.

(Exact name of registrant as specified in its charter)

Cayman Islands

001-39190

98-1518469

(State or other jurisdiction
of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

1220 L St NW, Suite 100-397
Washington, DC		20005
(Address of principal executive offices)		(Zip Code)

(202) 681-8461

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934: None.

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and one-half of one redeemable warrant to purchase one Class A ordinary share	SCVX.U	New York Stock Exchange
Class A ordinary shares, $0.0001 par value per share	SCVX	New York Stock Exchange
Redeemable warrants to purchase Class A ordinary shares	SCVX WS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of ~~November~~May 2924, ~~2021~~2022, 233,~~000~~792,~~000~~013 Class A ordinary shares, par value $0.0001, and 5,750,000 Class B ordinary shares, par value $0.0001, were issued and outstanding.

SCVX CORP.

Quarterly Report on Form 10-Q

Table of Contents

		Page No.	~~Page No.~~
PART I. FINANCIAL INFORMATION		1
Item 1.	Financial Statements	~~Financial Statements~~1	1
		Condensed Consolidated Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020 (Restated & Unaudited)	1
	Condensed Consolidated Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021	1
		Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2021 and 2020	2
	Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2022 and 2021	2
		Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the Three and Nine Months Ended September 30, 2021 and 2020	3
	Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three Months Ended March 31, 2022 and 2021	3
		Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2021 and 2020	4
	Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021	4
	Notes to Unaudited Condensed Consolidated Financial Statements	~~Notes to Unaudited Condensed Consolidated Financial Statements~~5	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	~~Management’s Discussion and Analysis of Financial Condition and Results of Operations~~18	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	~~Quantitative and Qualitative Disclosures About Market Risk~~22	29
Item 4.	Controls and Procedures	~~Controls and Procedures~~23	29
PART II. OTHER INFORMATION		24
Item 1.	Legal Proceedings	~~Legal Proceedings~~24	30
Item 1A.	Risk Factors	~~Risk Factors~~24	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	~~Unregistered Sales of Equity Securities and Use of Proceeds~~24	30
Item 3.	Defaults Upon Senior Securities	~~Defaults Upon Senior Securities~~24	31
Item 4.	Mine Safety Disclosures	~~Mine Safety Disclosures~~24	31
Item 5.	Other Information	~~Other Information~~24	31
Item 6.	Exhibits	~~Exhibits~~25	31
SIGNATURES		26	32

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

SCVX CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2021			December 31, 2020
	March 31, 2022			December 31, 2021
	(Unaudited)			~~(Restated & Unaudited)~~
Assets:
Current assets:
Cash	$	~~341~~284,~~458~~355		$	~~917~~145,~~238~~565
Prepaid expenses		85103,~~912~~593			6136,~~423~~405
Total current assets		~~427~~387,~~370~~948			~~978~~181,~~661~~970
Investments held in Trust Account		~~230~~38,~~559~~013,~~215~~873			230,~~548~~564,~~847~~071
Total Assets	$	~~230~~38,~~986~~401,~~585~~821		$	~~231~~230,~~527~~746,~~508~~041
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit:
Current liabilities:
Accounts payable	$	1,~~138~~172,~~285~~351		$	1,~~001~~158,~~499~~069
Accrued expenses		1,~~453~~780,~~569~~836			61,~~000~~610,938
Accrued expenses - related party		~~210~~270,000			~~120~~240,000
Total current liabilities		2,801,854			1,127,499
Note payable - related party		500,291			-
Total current liabilities		3,723,478			3,009,007
Deferred underwriting commissions		8,050,000			8,050,000
Warrant liabilities		143,~~678~~620,000			316,~~298~~220,000
Total Liabilities		2515,~~529~~393,~~854~~478			4017,~~475~~279,~~499~~007
Commitments and Contingencies (Note 5)
Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 shares at $10.02 per share as of September 30, 2021 and December 31, 2020		230,559,215			230,548,847
Class A ordinary shares subject to possible redemption, $0.0001 par value; 3,792,013 and 23,000,000 shares issued and outstanding at $10.02 per share redemption value as of March 31, 2022 and December 31, 2021, respectively		38,013,873			230,564,071
Shareholders’ Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of September 30, 2021 and December 31, 2020		-			-
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of March 31, 2022 and December 31, 2021		-			-
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized as of June 30, 2021 and December 31, 2020		-			-
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no non-redeemable shares issued or outstanding as of March 31, 2022 and December 31, 2021		-			-
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding at September 30, 2021 and December 31, 2020		575			575
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021		575			575
Accumulated deficit		(2515,~~103~~006,~~059~~105	)		(3917,~~497~~097,~~413~~612	)
Total shareholders’ deficit		(2515,~~102~~005,~~484~~530	)		(3917,~~496~~097,~~838~~037	)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit	$	~~230~~38,~~986~~401,~~585~~821		$	~~231~~230,~~527~~746,~~508~~041

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCVX CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Three Months Ended						~~For the Nine Months Ended~~
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
	March 31, 2022			March 31, 2021
Operating expenses
General and administrative expenses	$	~~707~~478,~~832~~493		$	~~141~~588,~~971~~682		$	~~2,135,646~~		$	~~1,824,621~~
Administrative fees - related party		30,000			30,000			~~90,000~~			~~90,000~~
Loss from operations		(~~737~~508,~~832~~493	)		(~~171~~618,~~971~~682	)		~~(2,225,646~~	)		~~(1,914,621~~	)
Change in fair value of warrant liabilities		42,~~887~~600,000			(813,~~656~~132,000	)		~~16,620,000~~			~~(6,088,000~~	)
Offering costs associated with warrants issuance		-			-			-			(790,510	)
Net gain from investments held in Trust Account		2,356			3,406
Net gain from investments held in Trust Account		3,481			20,853			10,368			544,541
Net income	$	2,093,863		$	12,516,724
Net income (loss)	$	4,152,649		$	(8,807,118	)	$	14,404,722		$	(8,248,590	)
Weighted average shares outstanding of Class A ordinary shares, basic and diluted		8,060,455			23,000,000
Weighted average shares outstanding of Class A ordinary shares, basic and diluted		23,000,000			23,000,000			23,000,000			20,733,577
Basic and diluted net income per Class A ordinary share	$	0.15		$	0.44
Basic and diluted net income (loss) per share, Class A ordinary shares	$	0.14		$	(0.31	)	$	0.50		$	(0.31	)
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		5,750,000			5,750,000
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		5,750,000			5,750,000			5,750,000			5,676,095
Basic and diluted net income per Class B ordinary share	$	0.15		$	0.44
Basic and diluted net income (loss) per share, Class B ordinary shares	$	0.14		$	(0.31	)	$	0.50		$	(0.31	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCVX CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ ~~EQUITY (~~DEFICIT)

For the Three ~~and Nine~~ Months Ended ~~September 30~~March 31, ~~2021~~2022

	Ordinary Shares								Additional			~~Total~~			Total
	Class A				Class B				~~Accumulated~~Paid-in			~~Shareholders’~~Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		~~Deficit~~Capital			Deficit			Deficit
Balance - December 31, 2020 - restated		-	$	-		5,750,000	$	575	$	(39,497,413	)	$	(39,496,838	)
Balance - December 31, 2021		-	$	-		5,750,000	$	575	$	-		$	(17,097,612	)	$	(17,097,037	)
Accretion on Class A ordinary shares subject to possible redemption amount (restated)		-		-		-		-		(3,406)			(3,406)
Accretion on Class A ordinary shares subject to possible redemption amount		-		-		-		-		-			(2,356	)		(2,356	)
Net income		-		-		-		-		~~12,516,724~~-			122,~~516~~093,~~724~~863			2,093,863
Balance - March 31, 2021 (unaudited) - restated		-		-		5,750,000		575		(26,984,095	)		(26,983,520	)
Balance - March 31, 2022 (unaudited)		-	$	-		5,750,000	$	575	$	-		$	(15,006,105	)	$	(15,005,530	)
Accretion on Class A ordinary shares subject to possible redemption amount (restated)		-		-		-		-		(3,481)			(3,481)
Net loss		-		-		-		-		(2,264,651	)		(2,264,651	)
Balance - June 30, 2021 (unaudited) - restated		-		-		5,750,000		575		(29,252,227	)		(29,251,652	)
Accretion on Class A ordinary shares subject to possible redemption amount (restated)		-		-		-		-		(3,481)			(3,481)
Net income		-		-		-		-		4,152,649			4,152,649
Balance - September 30, 2021 (unaudited)		-	$	-		5,750,000	$	575	$	(25,103,059	)	$	(25,102,484	)

For the Three ~~and Nine~~ Months Ended ~~September 30~~March 31, ~~2020~~2021

	Ordinary Shares								Additional						Total
	Class A				Class B				Paid-in			Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Capital			Deficit			~~Equity (~~Deficit)
Balance - December 31, 2019		-	$	-		5,750,000	$	575	$	24,425		$	(21,214	)	$	3,786
Balance - December 31, 2020		-	$	-		5,750,000	$	575	$	-		$	(39,497,413	)	$	(39,496,838	)
Accretion on Class A ordinary shares subject to possible redemption amount (restated)		-		-		-		-		(24,425	)		(26,090,196	)		(26,114,621	)
Accretion on Class A ordinary shares subject to possible redemption amount		-		-		-		-		-			(3,406	)		(3,406	)
Net income		-		-		-		-		-			12,~~022~~516,~~204~~724			12,~~022~~516,~~204~~724
Balance - March 31, 2020 (unaudited) - restated		-		-		5,750,000		575		-			(14,089,206	)		(14,088,631	)
Balance - March 31, 2021 (unaudited)		-	$	-		5,750,000	$	575	$	-		$	(26,984,095	)	$	(26,983,520	)
Accretion on Class A ordinary shares subject to possible redemption amount (restated)		-		-		-		-		-			(240,741)			(240,741)
Net loss		-		-		-		-		-			(11,463,676	)		(11,463,676	)
Balance - June 30, 2020 (unaudited) - restated		-		-		5,750,000		575		-			(25,793,623	)		(25,793,048	)
Accretion on Class A ordinary shares subject to possible redemption amount (restated)		-		-		-		-		-			(20,853)			(20,853)
Net loss		-		-		-		-		-			(8,807,118	)		(8,807,118	)
Balance - September 30, 2020 (unaudited) - restated		-	$	-		5,750,000	$	575	$	-		$	(34,621,594	)	$	(34,621,019	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCVX CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Nine Months Ended
	For the Three Months Ended
	September 30, 2021			September 30, 2020
	March 31, 2022			March 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$	14,404,722		$	(8,248,590	)
Net income	$	2,093,863		$	12,516,724
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Adjustments to reconcile net income to net cash used in operating activities:
General and administrative expenses paid by related party included in note payable		-			24,378
Change in fair value of warrant liabilities		(2,600,000	)		(13,132,000	)
Change in fair value of warrant liabilities		(16,620,000	)		6,088,000
Net gain from Investments held in Trust Account		(2,356	)		(3,406	)
Offering costs associated with warrants issuance		-			790,510
Accrued interest on note payable - related party		291			-
Share based compensation		-			1,452,000
Net gain from Investments held in Trust Account		(10,368	)		(544,541	)
Changes in operating assets and liabilities:
Prepaid expenses		(2467,~~489~~188	)		(~~114~~44,~~764~~152	)
Accounts payable		~~136~~14,~~786~~282			3610,~~043~~246
Accrued expenses		1169,~~447,569~~898			3472,~~280~~526
Accrued expenses - related party		9030,000			9030,000
Net cash used in operating activities		(~~575~~361,~~780~~210	)		(~~423~~150,~~684~~062	)
Cash Flows from Investing Activities
Cash deposited in Trust Account		-			(230,000,000	)
Cash withdrawn from Trust Account to redeem ordinary shares		192,552,554			-
Net cash used in investing activities		-			(230,000,000	)
Net cash provided by investing activities		192,552,554			-
Cash Flows from Financing Activities:
Proceeds received from initial public offering, gross		-			230,000,000
Proceeds from note payable to related party		500,000			-
Proceeds from private placement		-			6,600,000
Redemption of Class A ordinary shares		(192,552,554	)		-
Offering costs paid		-			(5,121,355	)
Net cash used in financing activities		(192,052,554	)		-
Repayment of note payable from related party		-			(139,043	)
Net change in cash		138,790			(150,062	)
Net cash provided by financing activities		-			231,339,602
Cash - beginning of the period		145,565			25,000
Net change in cash		(575,780	)		915,918
Cash - end of the period	$	284,355		$	(125,062	)
Cash - beginning of the period		917,238			25,000
Cash - end of the period	$	341,458		$	940,918
Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accrued expenses	$	-		$	5,000
Offering costs included in note payable	$	-		$	4,600
Deferred underwriting commissions in connection with the initial public offering	$	-		$	8,050,000
Accretion on Class A ordinary shares subject to possible redemption amount (restated)	$	10,368		$	26,376,215

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Note 1 —- Description of Organization, ~~Business~~ Business Operations and Going Concern

SCVX Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on November 15, 2019. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

As of ~~September~~March 3031, ~~2021~~2022, ~~the~~ the Company had not commenced any operations. All activity for the period from November 15, 2019 (inception) through ~~September~~March 3031, ~~2021 relates~~2022 relates to the Company’s formation and the Initial Public Offering (as defined below), and, since the closing of the Initial Public Offering, the search for and efforts toward completing an initial Business Combination. The Company will not generate any operating revenues ~~until~~ until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on investments held in the trust account from the proceeds derived from the Initial Public Offering.

The Company’s sponsor is SCVX USA LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on January 23, 2020. On January 28, 2020, the Company consummated an initial public offering (the “Initial Public Offering”) of 23,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), including the issuance of 3,000,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.3 million, inclusive of $8.1 million in deferred underwriting commissions (Note 5). The Company’s sponsor is SCVX USA LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on January 23, 2020.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,600,000 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $6.6 million, and incurring offering costs of approximately $21,000 (Note 4).

Upon the closing of the ~~Initial~~ Initial Public Offering and the Private Placement, $230.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and was invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act (of 1940, as ~~defined~~amended ~~below~~(the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act ~~of 1940, as amended (the “Investment Company Act”)~~.

The Company will provide its holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares are classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s Chief Financial Officer (or his or her designee) prior to execution. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.

The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or January 28, 2022 (the “Combination Period”) or (b) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

IfOn January 25, 2022, the Company isheld ~~unable~~an Extraordinary General Meeting (the “Extraordinary General Meeting”). At the Extraordinary toGeneral ~~complete~~Meeting, athe ~~Business~~shareholders ~~Combination~~approved ~~within~~to extend the ~~Combination~~date, ~~Period~~from January 28, 2022 to July 28, 2022, by which the Company ~~will~~much either (a) consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities or (b) (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In connection with the vote to approve the extension proposal, the holders of 19,207,987 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.02 per share, for an aggregate redemption amount of approximately $192.5 million. As such, approximately 84% of the Class A ordinary shares were redeemed and approximately 16% of the Class A ordinary shares remain outstanding. After the satisfaction of such redemptions, the balance in our trust account will be approximately $38.0 million.

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Going Concern

As of ~~September~~March 3031, ~~2021~~2022, ~~the~~ the Company had approximately $~~341~~284,000 in its operating bank accounts and a working capital deficit of approximately $23.43 million.

Prior to the completion of the Initial Public Offering and Private Placement, the Company’s liquidity needs were satisfied through a capital contribution of $25,000 from the Sponsor in exchange for the issuance of the Founder Shares, and a ~~borrowing~~loan of approximately $139,000 from the ~~under~~Sponsor ~~the~~pursuant ~~Note (as~~to ~~defined~~a ~~below)~~promissory note originally issued toon November 19, 2019 (the ~~Sponsor~~“Note”). The Company fully repaid the Note to the Sponsor on January 28, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, ~~in order to finance transaction costs in connection with a Business Combination,~~ the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, provide the Company ~~with~~loans ~~Working~~in ~~Capital~~order ~~Loans~~to ~~(as~~finance ~~defined~~transaction ~~below~~costs in ~~Note~~connection ~~4).~~with ~~The Working Capital Loans will either be repaid upon consummation of~~ a Business Combination, ~~without interest, or, at~~ (the ~~lender’s discretion, up to $1.5 million of such~~ “Working Capital Loans”). ~~may~~As ~~be convertible into warrants~~ of ~~the~~March ~~post-Business~~31, ~~Combination~~2022 ~~entity~~and atDecember a31, ~~price~~2021, ~~of $1.00~~there ~~per warrant.~~were ~~The~~no ~~warrants~~amounts ~~would~~outstanding beunder ~~identical~~any toWorking ~~the~~Capital ~~Private Placement Warrants~~Loans.

InOn February ~~connection~~23, ~~with~~2022, the Company~~’s assessment~~ ofissued ~~going~~an ~~concern~~unsecured ~~considerations~~promissory note in ~~accordance~~the ~~with~~principal ~~FASB~~amount ~~ASC Topic 205-40, “Basis~~ of ~~Presentation – Going Concern~~$500,~~” management~~000 to ~~has~~the ~~determined~~Sponsor ~~that~~ (the ~~working~~“Sponsor Note”). ~~capital~~The ~~deficit~~Sponsor ~~raises~~Note ~~substantial~~bears ~~doubt~~interest ~~about~~at ~~the~~a ~~Company’s~~rate ~~ability~~of 0.59% toper ~~continue~~annum asand ~~a going~~is ~~concern~~repayable ~~until~~on the earlier ofto ~~the~~occur ~~consummation~~ of ~~the~~(i) ~~Business Combination or~~ the ~~date~~closing of ~~the~~a ~~Company~~business iscombination ~~required~~and to(ii) ~~liquidate,~~July ~~January~~ 28, 2022., ~~The~~which ~~unaudited~~is ~~condensed~~the ~~consolidated~~date ~~financial~~by ~~statements~~which dothe ~~not~~Company ~~include~~must ~~any~~either ~~adjustment~~consummate ~~that~~a ~~might~~business becombination or ~~necessary~~cease ifall ~~the~~operations ~~Company is~~except ~~unable~~for tothe ~~continue~~purpose asof awinding ~~going~~up ~~concern~~(see Note 4).

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Basis of Presentation - Going Concern,” management has determined that the working capital deficit raises substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate, January 28, 2022. The unaudited condensed consolidated financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.

~~Proposed~~Note ~~Business~~2 ~~Combination~~- Basis of Presentation and Summary of Significant Accounting Policies

On May 15, 2021, the Company entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among the Company, Bloom Merger Sub Inc., a Delaware corporation and a wholly owned direct subsidiary of the Company (“Merger Sub”), and Bright Machines, Inc., a Delaware corporation (“Bright Machines”).

The Merger Agreement provides for, among other things, the following transactions: (i) at least one day prior to the Effective Time (as defined in the Merger Agreement), the Company will become a Delaware corporation (the “Redomicile”), (ii) immediately prior to the Effective Time, each outstanding share of preferred stock of Bright Machines will automatically convert into a share of common stock of Bright Machines, par value $0.0001 per share (“Bright Machines Common Stock”), at the then-effective conversion rate as calculated pursuant to the terms of the governing documents of Bright Machines (the “Preferred Stock Conversion”), (iii) at the Effective Time, Merger Sub will merge with and into Bright Machines, with Bright Machines as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly owned subsidiary of the Company (the “Merger”), with Bright Machines having the option to elect to cause the parties to restructure the transactions to add a second merger to take place immediately after the Effective Time whereby Bright Machines, as the surviving company in the Merger, would merge with and into the Company or a new limited liability company that is a wholly owned subsidiary of the Company and (iv) at the Effective Time, the Company’s name will be changed to “Bright Machines, Inc.” The Redomicile, the Merger and the other transactions contemplated by the Merger Agreement are hereinafter referred to as the “Business Combination”.

The Business Combination is subject to approval by the Company’s shareholders and the fulfillment of other customary closing conditions. The Company will apply to list the securities of the combined company on Nasdaq effective as of no later than the Effective Time of the Merger.

In accordance with the terms and subject to the conditions of the Merger Agreement, each share of Bright Machines Common Stock, following the Preferred Stock Conversion and other than any Cancelled Shares (as defined in the Merger Agreement) and Dissenting Shares (as defined in the Merger Agreement) shall be converted into the right to receive a number of shares of duly authorized, validly issued, fully paid and nonassessable common stock, par value $0.0001 per share, of the Company (“Company Common Stock”) at an exchange ratio determined in accordance with the Merger Agreement based on a pre-money enterprise value of Bright Machines of $1.1 billion and $10.00 price per share of Company Common Stock. In addition, in the event that the closing sale price of Company Common Stock exceeds certain price thresholds for 20 out of any 30 consecutive trading days during the first five years following the closing of the Business Combination (the “Closing”), up to an additional 23,000,000 shares of Company Common Stock may be issued to the parties that were holders of Bright Machines Common Stock immediately prior to the Effective Time of the Merger.

Concurrently with the execution of the Merger Agreement, the Company entered into subscription agreements (the “Subscription Agreements”) with certain investors (the “PIPE Investors”). Pursuant to the Subscription Agreements, the PIPE Investors agreed to subscribe for and purchase, and the Company agreed to issue and sell to such investors, an aggregate of 20,500,000 shares of Class A ordinary shares of the Company for a purchase price of $10.00 per share, for aggregate gross proceeds of $205,000,000 (the “PIPE Financing”). The closing of the PIPE Financing is contingent upon, among other things, the substantially concurrent consummation of the Business Combination.

Note 2 — Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2021~~ 2022 are not necessarily indicative of the results that may be expected through December 31, ~~2021~~2022 or any future periods.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K/A filed with the SEC on ~~July~~April 1328, ~~2021~~2022.

Principles of Consolidation

The condensed consolidated financial statements of the Company include its wholly-owned subsidiary in connection with the planned merger. All inter-company accounts and transactions are eliminated in consolidation.

Restatement to Previously Reported Financial Statements

The Company applies ASC 480 in classifying and measuring is Class A ordinary shares. This included classifying the Class A ordinary shares subject to possible redemption in temporary equity in the Company’s condensed balance sheets. However, the Company’s Amended and Restated Memorandum and Articles of Association specify that it will not redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon closing a Business Combination. As such, the Company has historically maintained shareholders’ equity of at least $5,000,001 by classifying a portion of the outstanding Class A ordinary shares in permanent equity.

In connection with the preparation of the Company’s condensed financial statements as of September 30, 2021, management identified errors made in its historical financial statements where, at the closing of the Company’s Initial Public Offering, the Company improperly presented its Class A ordinary shares subject to possible redemption. The Company previously determined the Class A ordinary shares subject to possible redemption to be equal to the redemption value of $10.00 per share while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that all of the Class A ordinary issued in the Initial Public Offering and Over-Allotment can be redeemed or become redeemable subject to the occurrence of future events considered outside of the Company’s control. Therefore, management concluded that the initial and subsequent carrying value of temporary equity should include all outstanding Class A ordinary shares, irrespective of the aggregate limitation on redemptions. As a result, the Company restated its previously filed financial statements to present all Class A ordinary shares subject to possible redemption as temporary equity and to recognize accretion from the initial book value to redemption value at the time of its Initial Public Offering and the Over-Allotment. The Company’s previously filed financial statements that contained the error were reported in the Company’s Form 8-K with its audited balance sheet as of January 28, 2020 (the "Post-IPO Balance Sheet"), the Form 10-K/A as of and for the year ended December 31, 2020, and the Form 10-Qs for the quarterly periods ended March 31, 2020, June 30, 2020, September 30, 2020, March 31, 2021, and June 30, 2021 (the "Affected Periods"). The Company has restated its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares.

The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of March 31, 2021 and the statement of operations and statement of cash flows for the three months ended March 31, 2021:

	As of March 31, 2021
	As Previously Reported			Adjustment			As Restated
Unaudited Condensed Balance Sheet
Total Assets	$	231,425,004			-		$	231,425,004
Total liabilities	$	27,856,271			-		$	27,856,271
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		198,568,730			31,983,523			230,552,253
Shareholders’ equity (deficit)
Preferred shares - $0.0001 par value		-			-			-
Class A ordinary shares - $0.0001 par value		314			(314	)		-
Class B ordinary shares - $0.0001 par value		575			-			575
Additional paid-in-capital		5,623,707			(5,623,707	)		-
Accumulated deficit		(624,593	)		(26,359,502	)		(26,984,095	)
Total shareholders’ equity (deficit)		5,000,003			(31,983,523	)		(26,983,520	)
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit)	$	231,425,004		$	-		$	231,425,004

	For the Three Months Ended March 31, 2021
	As Previously Reported			Adjustment			As Restated
Unaudited Condensed Statement of Operations
Loss from operations	$	(618,682	)	$	-		$	(618,682	)
Other (expense) income:
Change in fair value of warrant liabilities		13,132,000			-			13,132,000
Net gain from investments held in Trust Account		3,406			-			3,406
Total other income		13,135,406			-			13,135,406
Net income	$	12,516,724		$	-		$	12,516,724
Weighted average shares outstanding of Class A ordinary shares, basic and diluted		18,619,107			4,380,893			23,000,000
Basic and diluted net income per Class A ordinary share	$	0.00		$	0.44		$	0.44
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		10,130,893			(4,380,893	)		5,750,000
Basic and diluted net income per Class B ordinary share	$	1.24		$	(0.80	)	$	0.44

	For the Three Months Ended March 31, 2021
	As Previously Reported		Adjustment			As Restated
Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities:
Change in fair value of Class A ordinary shares subject to possible redemption	$	12,516,730	$	(12,516,730	)	$	-
Accretion of Class A ordinary shares subject to redemption amount	$	-	$	3,406		$	3,406

The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of June 30, 2021, the statement of operations for the three and six month periods ended June 30, 2021 and statement of cash flows for the six months ended June 30, 2021:

	As of June 30, 2021
	As Previously Reported			Adjustment			As Restated
Unaudited Condensed Balance Sheet
Total Assets	$	231,111,558			-		$	231,111,558
Total liabilities	$	29,807,476			-		$	29,807,476
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		196,304,080			34,251,654			230,555,734
Shareholders’ equity (deficit)
Preferred shares - $0.0001 par value		-			-			-
Class A ordinary shares - $0.0001 par value		337			(337	)		-
Class B ordinary shares - $0.0001 par value		575			-			575
Additional paid-in-capital		7,888,334			(7,888,334	)		-
Accumulated deficit		(2,889,244	)		(26,362,983	)		(29,252,227	)
Total shareholders’ equity (deficit)		5,000,002			(34,251,654	)		(29,251,652	)
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit)	$	231,111,558		$	-		$	231,111,558

	For the Three Months Ended June 30, 2021
	As Previously Reported			Adjustment			As Restated
Unaudited Condensed Statement of Operations
Loss from operations	$	(869,132	)	$	-		$	(869,132	)
Other (expense) income:
Change in fair value of warrant liabilities		(1,399,000	)		-			(1,399,000	)
Net gain from investments held in Trust Account		3,481			-			3,481
Total other expense		(1,395,519	)		-			(1,395,519	)
Net loss	$	(2,264,651	)	$	-		$	(2,264,651	)
Weighted average shares outstanding of Class A ordinary shares, basic and diluted		19,854,384			3,145,616			23,000,000
Basic and diluted net loss per Class A ordinary share	$	0.00		$	(0.08	)	$	(0.08	)
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		8,895,616			(3,145,616	)		5,750,000
Basic and diluted net loss per Class B ordinary share	$	(0.25	)	$	0.17		$	(0.08	)

	For the Six Months Ended June 30, 2021
	As Previously Reported			Adjustment			As Restated
Unaudited Condensed Statement of Operations
Loss from operations	$	(1,487,814	)	$	-		$	(1,487,814	)
Other income:					-
Change in fair value of warrant liabilities		11,733,000			-			11,733,000
Net gain from investments held in Trust Account		6,887			-			6,887
Total other income		11,739,887			-			11,739,887
Net income	$	10,252,073		$	-		$	10,252,073
Weighted average shares outstanding of Class A ordinary shares, basic and diluted		19,240,158			3,759,842			23,000,000
Basic and diluted net income per Class A ordinary share	$	0.00		$	0.36		$	0.36
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		9,509,842			(3,759,842	)		5,750,000
Basic and diluted net income per Class B ordinary share	$	1.08		$	(0.72	)	$	0.36

	For the Six Months Ended June 30, 2021
	As Previously Reported		Adjustment			As Restated
Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities:
Change in fair value of Class A ordinary shares subject to possible redemption	$	10,252,080	$	(10,252,080	)	$	-
Accretion of Class A ordinary shares subject to redemption amount	$	-	$	6,887		$	-

	As of December 31, 2020
	As Previously Reported			Adjustment			As Restated
Balance Sheet
Total Assets	$	231,527,508			-		$	231,527,508
Total liabilities	$	40,475,499			-		$	40,475,499
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		186,052,000			44,496,847			230,548,847
Shareholders’ equity (deficit)
Preferred shares - $0.0001 par value		-			-			-
Class A ordinary shares - $0.0001 par value		439			(439	)		-
Class B ordinary shares - $0.0001 par value		575			-			575
Additional paid-in-capital		18,140,312			(18,140,312	)		-
Accumulated deficit		(13,141,317	)		(26,356,096	)		(39,497,413	)
Total shareholders’ equity (deficit)		5,000,009			(44,496,847	)		(39,496,838	)
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit)	$	231,527,508		$	-		$	231,527,508

	For the Three Months Ended September 30, 2020
	As Previously Reported			Adjustment			As Restated
Unaudited Condensed Statement of Operations
Loss from operations	$	(171,971	)	$	-		$	(171,971	)
Other (expense) income:
Change in fair value of warrant liabilities		(8,656,000	)		-			(8,656,000	)
Net gain from investments held in Trust Account		20,853			-			20,853
Total other expense		(8,635,147	)		-			(8,635,147	)
Net loss	$	(8,807,118	)	$	-		$	(8,807,118	)
Weighted average shares outstanding of Class A ordinary shares, basic and diluted		19,919,867			3,080,133			23,000,000
Basic and diluted net loss per Class A ordinary share	$	0.00		$	(0.31	)	$	(0.31	)
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		8,830,133			(3,080,133	)		5,750,000
Basic and diluted net loss per Class B ordinary share	$	(1.00	)	$	0.69		$	(0.31	)

	For the Nine Months Ended September 30, 2020
	As Previously Reported			Adjustment			As Restated
Unaudited Condensed Statement of Operations
Loss from operations	$	(1,914,621	)	$	-		$	(1,914,621	)
Other (expense) income:					-
Change in fair value of warrant liabilities		(6,088,000	)		-			(6,088,000	)
Offering costs associated with issuance of public and private warrants		(790,510	)		-			(790,510	)
Net gain from investments held in Trust Account		544,541			-			544,541
Total other expense		(6,333,969	)		-			(6,333,969	)
Net loss	$	(8,248,590	)	$	-		$	(8,248,590	)
Weighted average shares outstanding of Class A ordinary shares, basic and diluted		18,303,169			2,430,407			20,733,577
Basic and diluted net loss per Class A ordinary share	$	0.02		$	(0.33	)	$	(0.31	)
Weighted average shares outstanding of Class B ordinary shares, basic and diluted		8,106,502			(2,430,407	)		5,676,095
Basic and diluted net loss per Class B ordinary share	$	(1.07	)	$	0.76		$	(0.31	)

	For the Nine Months Ended September 30, 2020
	As Previously Reported			Adjustment			As Restated
Unaudited Condensed Statement of Cash Flows - Supplemental disclosure of noncash activities:
Initial value of Class A ordinary shares subject to possible redemption	$	196,927,450		$	(196,927,450	)	$	-
Change in fair value of Class A ordinary shares subject to possible redemption	$	(6,003,935	)	$	6,003,935		$	-
Accretion of Class A ordinary shares subject to redemption amount	$	-		$	26,376,215		$	26,376,215

The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of January 28, 2020.

	As of January 28, 2020
	As Previously Reported			Adjustment			As Restated
Balance Sheet
Total Assets	$	231,822,638			-		$	231,822,638
Total liabilities	$	29,895,187			-		$	29,895,187
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		196,927,450			33,072,550			230,000,000
Shareholders’ equity (deficit)
Preferred shares - $0.0001 par value		-			-			-
Class A ordinary shares - $0.0001 par value		331			(331	)		-
Class B ordinary shares - $0.0001 par value		575			-			575
Additional paid-in-capital		7,277,051			(7,277,051	)		-
Accumulated deficit		(2,277,956	)		(25,795,168	)		(28,073,124	)
Total shareholders’ equity (deficit)		5,000,001			(33,072,550	)		(28,072,549	)
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ equity (deficit)	$	231,822,638		$	-		$	231,822,638

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.

138

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents atas ~~September~~of 30March 31, ~~2021~~2022 and December 31, ~~2020~~2021 within the operating cash account. The entire balance of investments held in Trust Account as of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021 are comprised of cash equivalents.

Investments Held in the Trust Account

The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in net gain from investments held in Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements” ~~(“ASC 820”)~~ equal or approximate the carrying amounts represented in the unaudited condensed consolidated balance sheets.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued shares purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The Company accounts for its warrants issued in connection with its Initial Public Offering and Private Placement as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed consolidated statements of operations. The fair value of warrants issued in connection with the Private Placement has been estimated using Monte-Carlo simulations at each balance sheet date. The fair value of the warrants issued in connection with the Initial Public Offering was initially measured using a Monte-Carlo simulation and subsequently been measured at each measurement date based on the market price of such warrants when separately listed and traded.

Offering Costs Associated with the Initial Public Offering

Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the unaudited condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Class A Ordinary Shares Subject to Possible Redemption

Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, all outstanding Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ ~~equity~~deficit section of the Company’s unaudited condensed consolidated ~~balance~~ balance sheets.

~~Effective~~Under ASC ~~with~~480, the ~~closing~~Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value,. ~~which~~The ~~resulted~~change in the carrying value of the redeemable Class A ordinary shares resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

1410

Net Income ~~(Loss)~~ per Ordinary Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average number of ordinary shares outstanding for the respective period.

The calculation of diluted net income ~~(loss)~~ per ordinary share does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering ~~and~~ and the Private Placement Warrants to purchase 18,100,000 Class A ordinary shares because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income ~~(loss)~~ per share is the same as basic net income ~~(loss)~~ per share for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2021~~2022 and ~~2020~~2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income ~~(loss)~~ per share for each class of ordinary shares:

	For the Three Months Ended				For the ~~Nine~~Three Months Ended
	September 30, 2021				September 30, 2021
	March 31, 2022				March 31, 2021
	Class A		Class B		Class A		Class B
Numerator:
Allocation of net income	$	31,~~322~~222,~~119~~081	$	~~830~~872,~~530~~782	$	1110,~~523~~013,~~777~~379	$	2,~~880~~503,~~945~~345
Denominator:
Weighted average ordinary shares outstanding, basic and diluted		238,~~000~~060,~~000~~455		5,750,000		23,000,000		5,750,000
Basic and diluted net income per ordinary share	$	0.1415	$	0.1415	$	0.5044	$	0.5044

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2020						September 30, 2020
	Class A			Class B			Class A			Class B
	(Restated)			(Restated)			(Restated)			(Restated)
Numerator:
Allocation of net loss	$	(7,045,694	)	$	(1,761,424	)	$	(6,615,879	)	$	(1,632,711	)
Denominator:
Weighted average ordinary shares outstanding, basic and diluted		23,000,000			5,750,000			20,733,577			5,676,095
Basic and diluted net loss per ordinary share	$	(0.31	)	$	(0.31	)	$	(0.31	)	$	(0.31	)

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2021~~2022 and ~~2020~~2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The Company is considered a Cayman Islands exempted company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

~~Share-Based Compensation~~11

The Company records non-cash compensation recognized as a result of the fair value of the Private Placement Warrants being in excess of the amount paid by the Sponsor, pursuant to FASB ASC Topic 718, “Share-based Compensation.”

Derivative Warrant Liabilities

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

Note 3 —- Initial Public Offering

On January 28, 2020, the Company sold 23,000,000 Units, including the issuance of 3,000,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit in the Initial Public Offering. Each Unit consists of one Class A ordinary share, and one-half of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (Note 6).

Note 4 —- Related Party Transactions

Founder Shares

In November 2019, the Sponsor purchased 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), for an aggregate price of $25,000. In December 2019, the Sponsor transferred an aggregate of 1,092,500 Founder Shares to members of the Company’s management team. The holders of the Founder Shares have agreed to forfeit up to an aggregate of 750,000 Founder Shares, on a pro rata basis, to the extent that the over-allotment option was not exercised in full by the underwriters. On January 28, 2020, the over-allotment option was exercised in full. Accordingly, no Founder Shares were forfeited.

The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (1) one year after the completion of the initial Business Combination and (2) the date on which the Company consummates a liquidation, merger, share exchange, reorganization, or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the lock-up.

Private Placement Warrants

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,600,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $6.6 million, and incurring offering costs of approximately $21,000. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. Certain proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Related Party Loans

On November 19, 2019, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses pursuant to ~~a promissory note (~~the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed approximately $139,000 under the Note and fully repaid this amount on January 28, 2020.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2021 and December 31, 2020, the Company had no borrowings under any Working Capital Loans.12

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company Working Capital Loans. If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under any Working Capital Loans.

On February 23, 2022, the Company issued an unsecured promissory note in the principal amount of $500,000 to SCVX USA LLC. The Sponsor Note bears interest at a rate of 0.59% per annum and is repayable on the earlier to occur of (i) the closing of a business combination and (ii) July 28, 2022, which is the date by which the Company must either consummate a business combination or cease all operations except for the purpose of winding up. The Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable. As of March 31, 2022, there were $500,000 Sponsor Note outstanding and approximately $291 accrued interest for the three months ended March 31, 2022.

Administrative Support Agreement

Commencing on the date that the Company’s securities were first listed on the New York Stock Exchange, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, administrative and support services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $30,000 ~~and $90,000~~ in expenses in connection with such services during the three ~~and nine~~ months ended ~~September~~March 3031, ~~2021~~2022 and ~~2020~~2021, ~~respectively,~~ as reflected in the accompanying unaudited condensed consolidated statements of operations. As of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021, $~~210~~270,000 and $~~120~~240,000 in accrued expenses with related party were outstanding, respectively, as reflected in the accompanying unaudited condensed consolidated balance sheets.

Note 5 —- Commitments & Contingencies

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised their over-allotment option on January 28, 2020.

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.6 million in the aggregate, which was paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $8.1 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

~~Note 6 —Warrants~~13

Note 6 - Warrants

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, the Company will use its reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. If the shares issuable upon exercise of the warrants are not registered under the Securities Act, the Company will be required to permit holders to exercise their warrants on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects, the Company will not be required to file or maintain in effect a registration statement, but the Company will use its reasonable best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the ordinary shares during the 20-trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the initial shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants):

●

in whole and not in part;

●

at a price of $0.01 per warrant;

●

upon a minimum of 30 days’ prior written notice of redemption; and

●

if, and only if, the last reported closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle any warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

Note 7 –- Class A Ordinary Shares Subject to to Possible Redemption

The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~ 2021, there were 3,792,013 and 23,000,000 Class A ordinary shares issued and subject to possible redemption, respectively.

As of ~~September~~March 3031, ~~2021~~2022, ~~Class~~ Class A ordinary shares reflected on the balance sheet is reconciled on the following table:

	As of September 30, 2021
	As of March 31, 2022
Gross proceeds received from Initial Public Offering	$	230,000,000
Less:
Fair value of Public Warrants at issuance		(13,340,000	)
Offering costs allocated to Class A ordinary shares		(12,491,674	)
Redemption of Class A ordinary shares		(192,552,554	)
Plus:
Accretion on Class A ordinary shares to redemption value		26,~~390~~398,~~889~~101
Class A ordinary shares subject to possible redemption	$	~~230~~38,~~559~~013,~~215~~873

As of December 31, ~~2020~~2021, Class A ordinary shares reflected on the balance sheet is reconciled on the following table:

	As of December 31, 2020
	As of December 31, 2021
Gross proceeds received from Initial Public Offering	$	230,000,000
Less:
Fair value of Public Warrants at issuance		(13,340,000	)
Offering costs allocated to Class A ordinary shares		(12,491,674	)
Plus:
Accretion on Class A ordinary shares to redemption value		26,~~380~~395,~~521~~745
Class A ordinary shares subject to possible redemption	$	230,~~548~~564,~~847~~071

20Note 8 - Shareholders’ Deficit

~~Note~~Class 8A —Ordinary ~~Shareholders’~~Shares - ~~Equity~~The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, there were 3,792,013 and 23,000,000 Class A ordinary shares outstanding, respectively, and all of which were subject to possible redemption and classified as temporary equity in the accompanying condensed consolidated balance sheets (~~Deficit~~see Note 7).

Class A Ordinary Shares — The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2021 and December 31, 2020, there were 23,000,000 Class A ordinary shares outstanding, and all of which were subject to possible redemption and classified as temporary equity in the accompanying condensed consolidated balance sheets. See Note 7.15

Class B Ordinary Shares —- The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of ~~September~~March 3031, ~~2021~~ ~~and~~2022 and December 31, ~~2020~~2021, there were 5,750,000 Class B ordinary shares outstanding.

Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided, that, prior to the Company’s initial Business Combination, holders of the Class B ordinary shares will have the right to elect all of the Company’s directors and remove members of the board of directors for any reason, and holders of the Class A ordinary shares will not be entitled to vote on the election of directors during such time.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the Initial Business Combination on a one-for-one basis, subject to adjustment for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which the Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of all ordinary shares issued and outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination.

Preferred Shares —- The Company is authorized to issue 1,000,000 preferred shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~2021, there were no ~~preferred~~ preferred shares issued or outstanding.

Note 9 - Fair Value Measurements

The ~~Company~~following ~~follows~~table ~~the guidance~~presents ininformation ~~ASC~~about ~~820~~the ~~for~~Company’s ~~its financial~~ assets and liabilities that are ~~re-~~measured ~~and reported~~ at fair value aton ~~each~~a ~~reporting~~recurring ~~period,~~basis ~~and~~as ~~non-financial assets~~of ~~and~~March ~~liabilities~~31, ~~that~~2022 and ~~are~~December ~~re-measured~~31, 2021 and ~~reported~~indicates atthe fair value athierarchy ~~least~~of ~~annually.~~the valuation inputs the Company utilized to determine such fair value:

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

	Fair Value Measured as of March 31, 2022
	Level 1		Level 2		Level 3		Total
Assets
Investments held in Trust Account - money market fund	$	38,013,873	$	-	$	-	$	38,013,873
Liabilities:
Warrant liabilities - public warrants	$	2,300,000	$	-	$	-	$	2,300,000
Warrant liabilities - private placement warrants	$	-	$	-	$	1,320,000	$	1,320,000

● Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

	Fair Value Measured as of December 31, 2021
	Level 1		Level 2		Level 3		Total
Assets
Investments held in Trust Account - money market fund	$	230,564,071	$	-	$	-	$	230,564,071
Liabilities:
Warrant liabilities - public warrants	$	3,910,000	$	-	$	-	$	3,910,000
Warrant liabilities - private placement warrants	$	-	$	-	$	2,310,000	$	2,310,000

21Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers between levels for the three months ended March 31, 2022 and 2021.

● Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.16

●The ~~Level~~fair 3:value ~~Unobservable~~of ~~inputs~~warrants issued in connection with the Private Placement has been estimated using Monte-Carlo simulation at each balance sheet date. The fair value of the warrants issued in connection with the Initial Public Offering was initially measured using a Monte-Carlo simulation at each measurement date and subsequently been measured based on the market price when separately listed and traded. For the three months ended March 31, 2022 and 2021, the Company’s ~~assessment~~recognized a charge to the unaudited condensed consolidated statements of operations resulting from a decrease in the ~~assumptions~~fair ~~that~~value ~~market~~of ~~participants~~warrant ~~would~~liabilities ~~use~~of approximately $2.6 million and $13.1 million, respectively, presented as change in ~~pricing~~fair value of derivative warrant liabilities on the ~~asset~~accompanying orunaudited ~~liability~~condensed consolidated statements of operations.

The ~~following~~change ~~table~~in ~~presents information about~~ the ~~Company’s assets and liabilities that are measured at~~ fair value of onthe aLevel ~~recurring~~3 ~~basis~~derivative atwarrant ~~September~~liabilities ~~30,~~for ~~2021 and~~three ~~December~~months ended March 31, ~~2020~~2022 and ~~indicates~~2021 ~~the~~is ~~fair~~summarized ~~value~~as ~~hierarchy of the valuation inputs the Company utilized to determine such fair value~~follows:

	Fair Value Measured as of September 30, 2021
Warrant liabilities at December 31, 2021	$	2,310,000
	Level 1			Level 2		Level 3		Total
Change in fair value of warrant liabilities		(990,000	)
Assets
Warrant liabilities at March 31, 2022	$	1,320,000
Investments held in Trust Account - money market fund	$	230,559,215		$	-	$	-	$	230,559,215
Liabilities:
Warrant liabilities - public warrants	$	9,200,000		$	-	$	-	$	9,200,000
Warrant liabilities - private warrants	$	-		$	-	$	5,478,000	$	5,478,000

	Fair Value Measured as of December 31, 2020
Warrant liabilities at December 31, 2020	$	11,748,000
	Level 1			Level 2		Level 3		Total
Change in fair value of warrant liabilities		(5,082,000	)
Assets
Warrant liabilities at March 31, 2021	$	6,666,000
Investments held in Trust Account - money market fund	$	230,548,847		$	-	$	-	$	230,548,847
Liabilities:
Warrant liabilities - public warrants	$	19,550,000		$	-	$	-	$	19,550,000
Warrant liabilities - private warrants	$	-		$	-	$	11,748,000	$	11,748,000

Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers between levels for the three and nine months ended September 30, 2021.

The fair value of warrants issued in connection with the Private Placement has been estimated using Monte-Carlo simulation at each balance sheet date. The fair value of the warrants issued in connection with the Initial Public Offering was initially measured using a Monte-Carlo simulation at each measurement date and subsequently been measured based on the market price when separately listed and traded. For the three and nine months ended September 30, 2021, the Company recognized a charge to the unaudited condensed consolidated statements of operations resulting from a decrease in the fair value of warrant liabilities of approximately $4.9 million and $16.6 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed consolidated statements of operations.

The change in the fair value of the Level 3 derivative warrant liabilities for three and nine months ended September 30, 2021 is summarized as follows:

Warrant liabilities at December 31, 2020	$	11,748,000
Change in fair value of warrant liabilities		(5,082,000	)
Warrant liabilities at March 31, 2021		6,666,000
Change in fair value of warrant liabilities		594,000
Warrant liabilities at June 30, 2021		7,260,000
Change in fair value of warrant liabilities		(1,782,000	)
Warrant liabilities at September 30, 2021	$	5,478,000

The estimated fair value of the derivative warrant liabilities is determined using Level 3 inputs. Inherent in a Monte-Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

The following table provides quantitative information regarding Level 3 fair value measurements inputs for warrant liabilities as their measurement dates:

	September 30, 2021			December 31, 2020
	March 31, 2022			December 31, 2021
Exercise price	$	11.50		$	11.50
Stock Price	$	9.9389		$	109.3099
Term (in years)		5.2550			5.5833
Volatility		133.3010	%		246.5085	%
Risk-free interest rate		12.0239	%		01.4428	%
Dividend yield		-			-

Note10 —- Subsequent Events

Management has evaluated subsequent events to determine if events or transactions occurring through the date the unaudited condensed consolidated financial statements were issued required potential adjustment to or disclosure in the unaudited condensed consolidated financial statements and has concluded that all such events that would require recognition or disclosure have been recognize or disclosed.

2317

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “SCVX Corp.” “our,” “us” or “we” refer to SCVX Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those relating to the proposed Business Combination described below and those described in our other SEC filings.

Overview

We are a blank check company incorporated as a Cayman Islands exempted company on November 15, 2019. We were formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies. Our sponsor is SCVX USA LLC, a Delaware limited liability company (the “Sponsor”).

The registration statement for our initial public offering (the “Initial Public Offering”) was declared effective on January 23, 2020. On January 28, 2020, we consummated the Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), including the issuance of 3,000,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.3 million, inclusive of $8.1 million in deferred underwriting commissions.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 6,600,000 warrants (the “Private Placement Warrants”) to our Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to us of $6.6 million, and incurring offering costs of approximately $21,000.

Upon the closing of the Initial Public Offering and the Private Placement, $230.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and was invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

2418

IfWe have weuntil ~~are~~July ~~unable~~28, 2022 to ~~complete~~ consummate a Business Combination ~~within 24 months from~~ (the ~~closing~~“Combination ofPeriod”). ~~the~~If ~~Initial~~we ~~Public~~are ~~Offering,~~unable orto ~~January~~complete ~~28,~~a ~~2022~~Business Combination (within the “Combination Period”), we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

~~Proposed~~On January ~~Business~~25, ~~Combination~~2022, we held an Extraordinary General Meeting (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the shareholders approved to extend the date, from January 28, 2022 to July 28, 2022, by which we much either (a) consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities or (b) (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In connection with the vote to approve the extension proposal, the holders of 19,207,987 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.02 per share, for an aggregate redemption amount of approximately $192.5 million. As such, approximately 84% of the Class A ordinary shares were redeemed and approximately 16% of the Class A ordinary shares remain outstanding. After the satisfaction of such redemptions, the balance in our trust account will be approximately $38.0 million.

On May 15, 2021, we entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among the Company, Bloom Merger Sub Inc., a Delaware corporation and a wholly owned direct subsidiary of the Company (“Merger Sub”), and Bright Machines, Inc., a Delaware corporation (“Bright Machines”).

The Merger Agreement provides for, among other things, the following transactions: (i) at least one day prior to the Effective Time (as defined in the Merger Agreement), we will become a Delaware corporation (the “Redomicile”), (ii) immediately prior to the Effective Time, each outstanding share of preferred stock of Bright Machines will automatically convert into a share of common stock of Bright Machines, par value $0.0001 per share (“Bright Machines Common Stock”), at the then-effective conversion rate as calculated pursuant to the terms of the governing documents of Bright Machines (the “Preferred Stock Conversion”), (iii) at the Effective Time, Merger Sub will merge with and into Bright Machines, with Bright Machines as the surviving company in the merger and, after giving effect to such merger, continuing as our wholly owned subsidiary (the “Merger”), with Bright Machines having the option to elect to cause the parties to restructure the transactions to add a second merger to take place immediately after the Effective Time whereby Bright Machines, as the surviving company in the Merger, would merge with and into us or a new limited liability company that is our wholly owned subsidiary and (iv) at the Effective Time, our name will be changed to “Bright Machines, Inc.” The Redomicile, the Merger and the other transactions contemplated by the Merger Agreement are hereinafter referred to as the “Business Combination”.

The Business Combination is subject to approval by our shareholders and the fulfillment of other customary closing conditions. We will apply to list the securities of the combined company on Nasdaq effective as of no later than the Effective Time of the Merger.

In accordance with the terms and subject to the conditions of the Merger Agreement, each share of Bright Machines Common Stock, following the Preferred Stock Conversion and other than any Cancelled Shares (as defined in the Merger Agreement) and Dissenting Shares (as defined in the Merger Agreement) shall be converted into the right to receive a number of shares of our duly authorized, validly issued, fully paid and nonassessable common stock, par value $0.0001 per share (“Company Common Stock”), at an exchange ratio determined in accordance with the Merger Agreement based on a pre-money enterprise value of Bright Machines of $1.1 billion and $10.00 price per share of Company Common Stock. In addition, in the event that the closing sale price of Company Common Stock exceeds certain price thresholds for 20 out of any 30 consecutive trading days during the first five years following the closing of the Business Combination (the “Closing”), up to an additional 23,000,000 shares of Company Common Stock may be issued to the parties that were holders of Bright Machines Common Stock immediately prior to the Effective Time of the Merger.

Concurrently with the execution of the Merger Agreement, we entered into subscription agreements (the “Subscription Agreements”) with certain investors (the “PIPE Investors”). Pursuant to the Subscription Agreements, the PIPE Investors agreed to subscribe for and purchase, and we agreed to issue and sell to such investors, an aggregate of 20,500,000 of our Class A ordinary shares for a purchase price of $10.00 per share, for aggregate gross proceeds of $205,000,000 (the “PIPE Financing”). The closing of the PIPE Financing is contingent upon, among other things, the substantially concurrent consummation of the Business Combination.

Results of Operations

Our entire activity since ~~inception~~ inception up to ~~September~~March 3031, ~~2021~~2022 relates to our formation, the Initial Public Offering and, since the closing of the Initial Public Offering, a search for and efforts toward completing an initial Business Combination. We will not be generating any operating revenues until the closing and completion of our initial Business Combination, at the earliest.

For the three months ended ~~September~~March 3031, ~~2021~~2022, we had net income of approximately $4.2.1 million, which consisted of an ~~approximately~~ $42.96 million gain from changes in fair value of warrant liabilities and approximately $32,000 in interest earned from investments held in the Trust Account, partially offset by approximately $~~708~~478,000 general and administrative expenses and $30,000 of related party administrative fees.

For the ~~nine~~three months ended ~~September~~March 3031, 2021, we had net income of approximately $1412.45 million, which consisted of an approximately $1613.61 million gain from changes in fair value of warrant liabilities and approximately $103,000 in interest earned from investments held in the Trust Account, partially offset by approximately $~~2.1~~589,000 ~~million~~ in general and administrative expenses and $9020,000 of related party administrative fees.

For the three months ended September 30, 2020, we had a net loss of approximately $8.8 million, which consisted of approximately $142,000 in general and administrative expenses, $30,000 of related party administrative fees and an approximately $8.7 million loss from changes in fair value of warrant liabilities, partially offset by approximately $21,000 in interest earned from investments held in the Trust Account.

For the nine months ended September 30, 2020, we had a net loss of approximately $8.2 million, which consisted of approximately $1.8 million in general and administrative expenses, $90,000 of related party administrative fees, an approximately $6.1 million loss from changes in the fair value of warrant liabilities and approximately $791,000 offering costs associated with issued public and private warrants, partially offset by approximately $545,000 in interest earned from investments held in the Trust Account.

Liquidity, Capital Resources and Going Concern

As of ~~September~~March 3031, ~~2021~~2022, we had approximately $~~341~~284,000 in our operating bank accounts and working capital deficit of approximately $23.43 million.

Prior to the completion of the Initial Public Offering, our liquidity needs were satisfied through a ~~payment~~capital contribution of $25,000 from the ~~Company’s Chairman and~~ ~~Co-Chief~~Sponsor ~~Executive Officer to cover for certain offering costs~~ in exchange for the issuance of the Founder Shares, and ~~the~~a loan ~~under the Note~~ of approximately $139,000 tofrom usthe Sponsor pursuant to ~~cover~~a ~~for~~promissory note ~~offering~~originally ~~costs~~issued inon ~~connection~~November ~~with~~19, 2019 (the ~~Initial~~“Note”). ~~Public~~We ~~Offering~~fully repaid the Note on January 28, 2020. Subsequent to the consummation of the Initial Public Offering on January 28, 2020, the liquidity needs have been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. WeIn ~~fully~~addition, ~~repaid~~our ~~the~~officers, ~~Note~~directors onand ~~January~~initial 28shareholders may, ~~2020.~~but Inare ~~addition~~not obligated to, provide us loans in order to finance transaction costs in connection with a Business Combination, ~~our~~(the ~~officers,~~“Working Capital ~~directors~~Loans”). ~~and~~As ~~initial~~of ~~shareholders~~March ~~may~~31, ~~but are~~2022 ~~not~~and ~~obligated~~December to31, ~~provide~~2021 ~~us Working Capital Loans. To date,~~ there were no amounts outstanding under any Working Capital Loans.

Based on the foregoing, management has determined that the working capital deficit raises substantial doubt about our ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date we are required to liquidate, January 28, 2022. The unaudited condensed consolidated financial statements do not include any adjustment that might be necessary if we are unable to continue as a going concern.19

On February 23, 2022, we issued an unsecured promissory note in the principal amount of $500,000 to our Sponsor (the “Sponsor Note”). The Sponsor Note bears interest at a rate of 0.59% per annum and is repayable on the earlier to occur of (i) the closing of a business combination and (ii) July 28, 2022, which is the date by which the Company must either consummate a business combination or cease all operations except for the purpose of winding up.

In connection with our assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, “Presentation of Financial Statements – Going Concern,” we have determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after July 28, 2022. The financial statements do not include any adjustment that might be necessary if we are unable to continue as a going concern.

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

26In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The impact of this action and related sanctions on the world economy are not determinable as of the date of this Report. Further, the specific impact of this action on our financial condition, results of operations, and cash flows is also not determinable as of the date of this Report.

Contractual Obligations

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

We granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised their over-allotment option on January 28, 2020.

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.6 million in the aggregate, which was paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $8.1 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Administrative Support Agreement

Commencing on the date that our securities were first listed on the New York Stock Exchange, we agreed to pay the Sponsor a total of $10,000 per month for office space, administrative and support services. Upon completion of the Initial Business Combination or our liquidation, we will cease paying these monthly fees. We incurred $30,000 ~~and $90,000~~ in expenses in connection with such services during the three ~~and nine~~ months ended ~~September~~ 30March 31, ~~2021~~2022 and ~~2020~~ 2021, ~~respectively,~~ as reflected in the accompanying unaudited condensed consolidated statements of operations. As of ~~September~~March 3031, ~~2021~~2022 and December 31, ~~2020~~ 2021, $~~210~~270,000 and $~~120~~240,000 in accrued expenses with related party were outstanding, respectively, as reflected in the accompanying condensed consolidated balance sheets.

Critical Accounting Policies and Estimates

The preparation of unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following as our critical accounting policies:

Class A Ordinary Shares Subject to Possible Redemption

Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, all of our Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of our unaudited condensed consolidated balance sheets.

~~Net~~Under ASC ~~Income~~480, we have elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, we recognized the accretion from initial book value to redemption amount value. The change in the carrying value of the redeemable Class A ordinary shares resulted in charges against additional paid-in capital (~~Loss~~to the extent available) ~~per~~and ~~Ordinary~~accumulated ~~Share~~deficit.

Net Income per Ordinary Share

We comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average number of ordinary shares outstanding for the respective period.

27The calculation of diluted net income per ordinary share does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase 18,100,000 Class A ordinary shares because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three months ended March 31, 2022 and 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase 18,100,000 Class A ordinary shares because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2021 and 2020. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

Derivative Warrant Liabilities

We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of its financial instruments, including issued shares purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

We account for its warrants issued in connection with its Initial Public Offering and Private Placement as derivative warrant liabilities in accordance with ASC 815. Accordingly, we recognize the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the unaudited condensed consolidated statements of operations. The fair value of warrants issued in connection with the Private Placement has been estimated using Monte-Carlo simulations at each balance sheet date. The fair value of the warrants issued in connection with the Initial Public Offering was initially measured using a Monte-Carlo simulation and subsequently been measured at each measurement date based on the market price of such warrants when separately listed and traded.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact our financial position, results of operations or cash flows.

Our management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

Off-Balance Sheet Arrangements

As of ~~September~~March 3031, ~~2021~~2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As of ~~September~~March 3031, ~~2021~~2022, we were not subject to any market or interest rate risk. On January 28, 2020, the net proceeds of the Initial Public Offering, including ~~amounts~~ amounts in the Trust Account, were invested in U.S. government securities with a maturity of 185 days or less or in money market funds that meet certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, that invest only in direct U.S. government ~~treasury~~ treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

We have not engaged in any hedging activities since our inception and we do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

~~Our~~Disclosure ~~management~~controls ~~evaluated,~~and procedures are designed with the ~~participation~~objective of ~~our~~ensuring ~~current~~that ~~chief executive~~information ~~officer~~required ~~and~~to ~~chief~~be ~~financial~~disclosed ~~officer~~in (our ~~“Certifying~~reports ~~Officers”),~~filed under the ~~effectiveness~~Exchange ofAct, ~~our disclosure controls and~~such ~~procedures~~ as ofthis ~~September~~Report, 30is recorded, ~~2021~~processed, ~~pursuant~~summarized, toand ~~Rule~~reported ~~13a-15(b)~~within ~~under~~ the ~~Exchange~~time ~~Act.~~period ~~Based~~specified ~~upon~~in ~~that~~the ~~evaluation,~~SEC’s ~~our~~rules ~~Certifying~~and ~~Officers~~forms. ~~concluded~~Disclosure ~~that our disclosure~~ controls and procedures ~~were~~are ~~effective~~also asdesigned with the objective of ~~September~~ensuring ~~30,~~that ~~2021.~~such ~~Based~~information onis ~~this~~accumulated ~~evaluation,~~and communicated to our management, including the chief executive officer and chief financial officer, ~~have~~as ~~concluded~~appropriate ~~that~~to ~~during~~allow ~~the~~timely ~~period~~decisions ~~covered~~regarding required bydisclosure. ~~this~~Based ~~report~~upon their evaluation, our ~~disclosure~~Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of ~~September~~March 3031, ~~2021~~2022, because of a material weakness in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of ~~the~~our ~~Company’s~~ annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, ~~the~~our ~~Company’s~~ management has concluded that our control around the interpretation and accounting for ~~certain~~ complex ~~features~~financial ofinstruments ~~the Class A ordinary shares and warrants issued by the Company~~ was not effectively designed or maintained. This material weakness resulted in the restatement of ~~the~~our ~~Company’s~~audited ~~balance~~annual ~~sheet~~financial statements as of ~~January~~and 28for the period ended December 31, 2020, and ~~all~~our ~~of its~~ interim financial statements and ~~annual~~notes ~~financial~~for ~~statement through~~ the ~~period~~quarters ended March 31, 2021, June 30, 2021~~. Additionally~~, ~~this~~and ~~material~~September ~~weakness~~30, ~~could~~2021. ~~result~~In inlight ~~a misstatement~~ of ~~the~~this ~~warrant~~material ~~liability~~weakness, ~~Class~~we Aperformed ~~ordinary~~additional ~~shares~~analysis ~~and~~as ~~related~~deemed ~~accounts~~necessary ~~and~~to ~~disclosures~~ensure that ~~would~~our ~~result~~financial instatements awere ~~material~~prepared ~~misstatement~~in ofaccordance with U.S. GAAP. Accordingly, management believes that the condensed consolidated financial statements ~~that~~included in ~~would~~this ~~not~~Quarterly beReport ~~prevented~~on orForm ~~detected~~10-Q onpresent afairly ~~timely~~in ~~basis~~all material respects our financial position, results of operations and cash flows for the period presented.

~~Disclosure~~We ~~controls~~do ~~and~~not ~~procedures are~~expect that our disclosure controls and ~~other~~ procedures ~~that~~will ~~are~~prevent ~~designed~~all toerrors ~~ensure~~and ~~that~~all ~~information~~instances ~~required~~of tofraud. beDisclosure ~~disclosed~~controls inand ~~our~~procedures, ~~reports~~no ~~filed~~matter orhow ~~submitted~~well conceived ~~under~~and ~~the~~operated, ~~Exchange~~can ~~Act~~provide isonly ~~recorded~~reasonable, ~~processed~~not absolute, ~~summarized~~assurance that the objectives of the disclosure controls and ~~reported~~procedures ~~within~~are met. Further, the ~~time~~design ~~periods~~of ~~specified~~disclosure incontrols and procedures must reflect the ~~SEC’s~~fact ~~rules~~that there are resource constraints, and the benefits ~~forms~~must be considered relative to their costs. ~~Disclosure~~Because of the inherent limitations in all disclosure controls and procedures ~~include~~, ~~without~~no ~~limitation,~~evaluation of disclosure controls and procedures ~~designed~~can toprovide ~~ensure~~absolute assurance that ~~information~~we ~~required to~~have bedetected ~~disclosed~~all inour ~~company~~control ~~reports~~deficiencies ~~filed~~and orinstances of ~~submitted~~fraud, ~~under~~if ~~the~~any. ~~Exchange~~The ~~Act~~design isof ~~accumulated~~disclosure controls and ~~communicated~~procedures toalso ~~management,~~is ~~including our~~based ~~chief~~partly ~~executive~~on ~~officer~~certain ~~and~~assumptions ~~chief~~about ~~financial~~the ~~officer~~likelihood of future events, toand ~~allow~~there ~~timely~~can ~~decisions~~be ~~regarding~~no ~~required~~assurance ~~disclosure~~that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in internal control over financial reporting

~~There~~During ~~was~~the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting ~~that~~ ~~occurred~~(as ~~during~~such ~~the~~term ~~fiscal~~is ~~quarter~~defined ~~ended~~in ~~September~~Rules ~~30,~~13a-15(f) and ~~2021,~~15d-15(f) ~~covered~~of bythe ~~this~~Exchange ~~Quarterly~~Act) ~~Report on Form 10-Q~~ that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, except for the below. ~~The material weakness discussed below was remediated during the quarter ended September 30, 2021.~~

~~Our~~The ~~chief~~Chief ~~executive~~Executive ~~officer~~ Officer and ~~chief~~Chief ~~financial~~Financial ~~officer~~Officer performed additional accounting and financial analyses and other post-closing procedures including consulting with subject matter experts related to the accounting for certain complex ~~features~~financial ofinstruments ~~the~~issued ~~Class~~by Athe ~~ordinary shares and warrants~~Company. ~~The~~Our ~~Company’s~~ management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.

2923

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

There are no material changes to the risk factors in our most recent Annual Report on Form 10-K/A as filed with the SEC on ~~July~~April 1328, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement of 6,600,000 Private Placement Warrants to our Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds of $6.6 million. Each Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The Private Placement Warrants may be exercised only for a whole number of shares. If we do not complete our initial Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will not be redeemable by us and will be exercisable on a cashless basis so long as they are held by our Sponsor or its permitted transferees. If the Private Placement Warrants are held by holders other than our Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by us and exercisable by the holders on the same basis as the Public Warrants included in the Units sold in the Initial Public Offering. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise thereof) will not be transferable, assignable or salable until 30 days after the completion of our initial Business Combination. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. Our Sponsor is an accredited investor for purposes of Rule 501 of Regulation D. No underwriting discounts or commissions were paid with respect to such sale.

Use of Proceeds

On January 28, 2020, we consummated the Initial Public Offering of 23,000,000 Units, including the issuance of 3,000,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $230.0 million. Each Unit consists of one Class A ordinary share and one-half of one Public Warrant. Each Public Warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The Units sold in the Initial Public Offering were registered under the Securities Act on our registration statement on Form S-1, as amended (File No. 333-235694). The registration statement for the Initial Public Offering was declared effective on January 23, 2020. Credit Suisse Securities (USA) LLC acted as sole book-running manager.

In connection with the Initial Public Offering, we incurred offering costs of approximately $13.3 million, inclusive of $4.6 million in underwriting discounts and $8.1 million in deferred underwriting commissions. Substantially concurrently with the closing of the Initial Public Offering, we also repaid our Sponsor $139,000 in full satisfaction of the Note. After deducting the underwriting discounts and commissions (excluding the deferred portion, which amount will become payable solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement) and other offering costs and expenses, the net proceeds from the Initial Public Offering and Private Placement was approximately $231.4 million. A total of $230.0 million, comprised of certain of the net proceeds of the Initial Public Offering and the Private Placement, was placed in the Trust Account, and was invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account. As of September 30, 2021, we held approximately $341,000 outside of the Trust Account available to us for our activities in connection with identifying a suitable Business Combination and for general working capital purposes.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibit Number		Description
31.1		Certification of Chief Executive Officer and Director (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer and Secretary (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer and Director (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Chief Financial Officer and Secretary (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		Inline XBRL Instance Document.

101.SCH		Inline XBRL Taxonomy Extension Schema Document.

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

3125

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SCVX Corp.
Date: November 29, 2021	By:	/s/ Michael Doniger
Date: May 24, 2022	By:	/s/ Michael Doniger
	Name:	Michael Doniger
	Title:	Chief Executive Officer and Chairman

3226

Filing Compare · SCVX Corp.